drugset
Drugs / Interferon-ß-1a
last change Mar 2021 re-read 3 minutes ago

Interferon-ß-1a

also known as IFNβ-1a · Interferon β-1a
Developed for
COVID-19
Investigated by
Emanuele Bosi

Trials 1

today NCT04449380 · Ph 2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04449380 Nov 2020 → Mar 2021 COVID-19 Emanuele Bosi Terminated No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Interferon-ß-1a ClinicalTrials.gov intervention name — accepted as the source's own label NCT04449380 ↗
Known as IFNβ-1a “Randomized, Controlled, Open Label, Phase 2 Clinical Trial of Interferon-β-1a (IFNβ-1a) in COVID-19 Patients” NCT04449380 ↗
Known as Interferon β-1a “Randomized, Controlled, Open Label, Phase 2 Clinical Trial of Interferon-β-1a (IFNβ-1a) in COVID-19 Patients” NCT04449380 ↗
Route Subcutaneous “IFNβ-1a will be administered subcutaneously at the dose of 44 mcg” PMID 33225960 ↗ Nov 2020